Kevin Koch, President and CEO: Edgewise Therapeutics EWTX Sell · Filed 25/05/07

Trade details

Type: Insider sale
Amount: $70,340.2
Shares · price: 4,276 sh · $16.45 a share
Held after: 20,619 sh
Stock: Edgewise Therapeutics EWTX
Person: Kevin KochPresident and CEO
Trade date: 25/05/02
Filed: 25/05/07
Days to filing: 5 days

Sold 17.2% of holdings

Share of holding sold: 17.2%

Edgewise Therapeutics trades, last 26 weeks

What else happened in Edgewise Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/02~25/06/01

Kevin Koch's recent trades

Kevin KochPresident and CEO
SellEdgewise Therapeutics
Sell
Edgewise Therapeutics
EWTX
$106.7K
7,972 sh
$106.7K
Filed 25/08/14
Traded 25/08/12
Kevin KochPresident and CEO
Sell10b5-1 planEdgewise Therapeutics
Sell10b5-1 plan
Edgewise Therapeutics
EWTX
$3,000
100 sh
$3,000
Filed 25/03/11
Traded 25/03/07
Kevin KochPresident and CEO
Sell10b5-1 planEdgewise Therapeutics
Sell10b5-1 plan
Edgewise Therapeutics
EWTX
$259.3K
8,636 sh
$259.3K
Filed 25/02/07
Traded 25/02/05
Kevin KochPresident and CEO
Sell10b5-1 planEdgewise Therapeutics
Sell10b5-1 plan
Edgewise Therapeutics
EWTX
$28K
900 sh
$28K
Filed 25/02/07
Traded 25/02/06
Koch KevinDirector, Officer
Planned sale10b5-1 planEdgewise Therapeutics
Planned sale10b5-1 plan
Edgewise Therapeutics
EWTX
$1.5M
51,181 sh
$1.5M
Filed 25/02/05
Traded 25/02/05